{
  "ticker": "LH",
  "year": 2023,
  "quarter": 1,
  "last_updated": "2025-04-15T14:01:53.509490",
  "count": 54,
  "transactions": [
    {
      "id": 53848,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3234",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4903"
    },
    {
      "id": 53856,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3381",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5345.9485"
    },
    {
      "id": 53857,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "42353",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65534"
    },
    {
      "id": 53865,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-03-30",
      "transaction_shares": "11715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47355"
    },
    {
      "id": 53870,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3609",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9161.7592"
    },
    {
      "id": 53883,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13450.4022"
    },
    {
      "id": 53895,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23175.7624"
    },
    {
      "id": 53896,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "1798",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3958.2194"
    },
    {
      "id": 53898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15832"
    },
    {
      "id": 53909,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "4509",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24677"
    },
    {
      "id": 53894,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-02",
      "transaction_shares": "1340",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2043"
    },
    {
      "id": 53888,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-21",
      "transaction_shares": "3000",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17069"
    },
    {
      "id": 53846,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-14",
      "transaction_shares": "309",
      "transaction_price": "247.63",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 53828,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7587"
    },
    {
      "id": 53840,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20253"
    },
    {
      "id": 53849,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-11",
      "transaction_shares": "483",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14211"
    },
    {
      "id": 53851,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7110.4022"
    },
    {
      "id": 53862,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "180",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "757"
    },
    {
      "id": 53868,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10951"
    },
    {
      "id": 53872,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5630.7592"
    },
    {
      "id": 53873,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "2656",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "24351"
    },
    {
      "id": 53877,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "236",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2033.9485"
    },
    {
      "id": 53878,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7765"
    },
    {
      "id": 53881,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17004"
    },
    {
      "id": 53882,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20275"
    },
    {
      "id": 53885,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-11",
      "transaction_shares": "723",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35835"
    },
    {
      "id": 53892,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16536.7624"
    },
    {
      "id": 53897,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10996"
    },
    {
      "id": 53899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2672"
    },
    {
      "id": 53900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "110",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2198.2194"
    },
    {
      "id": 53903,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7173"
    },
    {
      "id": 53904,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1345"
    },
    {
      "id": 53850,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-07",
      "transaction_shares": "409",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 53879,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-07",
      "transaction_shares": "219",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "5340.7592"
    },
    {
      "id": 53829,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5640.7592"
    },
    {
      "id": 53836,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "150",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2140.2194"
    },
    {
      "id": 53839,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "280",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1881.9485"
    },
    {
      "id": 53841,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "267",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "660"
    },
    {
      "id": 53845,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7247.4022"
    },
    {
      "id": 53853,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16277.7624"
    },
    {
      "id": 53861,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-04",
      "transaction_shares": "970",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35373"
    },
    {
      "id": 53884,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13892"
    },
    {
      "id": 53891,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "3507",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23063"
    },
    {
      "id": 53911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "374",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20071"
    },
    {
      "id": 53843,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-02",
      "transaction_shares": "767",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "34609"
    },
    {
      "id": 53844,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "470"
    },
    {
      "id": 53852,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "237",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5577.7592"
    },
    {
      "id": 53860,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1678.9485"
    },
    {
      "id": 53863,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "117",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2031.2194"
    },
    {
      "id": 53864,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "2773",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20361"
    },
    {
      "id": 53876,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "15861.7624"
    },
    {
      "id": 53887,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13473"
    },
    {
      "id": 53890,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7130.4022"
    },
    {
      "id": 53901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "297",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "19799"
    }
  ]
}